[Hypofractionated stereotactic radiotherapy of bone metastases] - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue Cancer/Radiothérapie Année : 2014

[Hypofractionated stereotactic radiotherapy of bone metastases]


Hypofractionated stereotactic radiotherapy can deliver high doses of bone metastases while sparing adjacent healthy tissue not only for a decompressive or analgesic purpose, but also to improve the local control of the irradiated region. Various phases I or II studies showed the feasibility of such an approach at the cost of limited toxicity, including during re-irradiation. Hypofractionated stereotactic radiotherapy to oligometastases may also improve the long-term control of metastatic disease.
Fichier non déposé

Dates et versions

hal-02168047 , version 1 (28-06-2019)



B. Pichon, F. Thillays, Céline Bourgier, M. A. Mahe, S. Supiot. [Hypofractionated stereotactic radiotherapy of bone metastases]. Cancer/Radiothérapie, 2014, 18, pp.342--9. ⟨10.1016/j.canrad.2014.04.005⟩. ⟨hal-02168047⟩
34 Consultations
0 Téléchargements



Gmail Mastodon Facebook X LinkedIn More